Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Link Resources announces completion of share exchange transaction and private placement

Link Resources, Inc. announced today the completion of a share exchange transaction and concurrent US$12 million private placement pursuant to which it acquired the parent company of Yantai Bohai Pharmaceuticals Group Co., Ltd. (“Bohai”).

6 Jan 2010

BioVectra signs agreements with Sandoz to commercialize and market Docetaxel

BioVectra Inc. announced today it has signed agreements with Sandoz Inc. of Princeton, New Jersey, for Sandoz to commercialize and market the Abbreviated New Drug Application (ANDA) for Docetaxel for injection, the generic version of Taxotere®, developed by BioVectra.

6 Jan 2010

Laureate Pharma, Selexis SA collaborate to provide streamlined access to complementary contract services

Laureate Pharma, Inc. a US based biopharmaceutical contract manufacturing organization and Selexis SA, a Swiss based contract developer of high performance production cell lines, jointly announced today their continued collaboration via a joint-marketing relationship. This expanded relationship provides streamlined access to a set of highly complementary contract services.

6 Jan 2010

U.S. health spending slows in '08, but federal share soars

A new government report shows that U.S. health spending grew 4.4 percent in 2008 to $2.3 trillion, the slowest annual rate of increase since federal tracking efforts began in 1960, USA Today reports.

6 Jan 2010

MedApps receives CE Mark and CMDCAS certifications to distribute its products in Europe and Canada

MedApps, Inc., a leading Mobile Wireless Remote Patient Monitoring solution, announced today that it has successfully completed rigorous audits of its Quality Management System (QMS) and received ISO 13485:2003, ISO 9001:2008 and MDD from Underwriters Laboratories (UL), one of the most challenging auditing bodies in the world.

5 Jan 2010

Derma Sciences signs contract to produce finger bandages

Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, has finalized a contract with a leading global healthcare products company to produce finger bandages

5 Jan 2010

Health and hard-earned money traded on high-fat, poor-quality food

Dr. Sasson Moulavi, M.D., in a recent blog commented that food advertising is such a science that the average consumer does not have any chance of resisting when tempted by high-sugar, high-fat foods. In 2008, food and beverage companies spent $13.44 billion on advertising according to Advertising Age (6/09) and WPP's TNS Media Intelligence reporting.

5 Jan 2010

Vienna scientists develop new technique for producing H1N1 vaccines

Scientists in Vienna have developed a new technique for producing vaccines for H1N1, 'swine flu', based on insect cells. The research, published today in the Biotechnology Journal, reveals how influenza vaccines can be produced faster than through the traditional method of egg-based production, revealing a new strategy for the fight against influenza pandemics.

5 Jan 2010

Comprehensive studies on nanotechnology's HSE aspects vital

The advent of nanotechnology on the modern landscape has dramatically changed the shape, size, quality, cost, and efficiency of various applications. Nanotechnology is believed to be the most path-breaking technology, with this market expected to reach $1 trillion by 2015. The remarkable properties of the various nanomaterials have caught the attention of scientists, researchers, and manufacturers alike, and ongoing research activities are underway to harness their potential for the overall betterment of society.

5 Jan 2010

Positive results from Pearl Therapeutics' PT005 Phase 2a trial for COPD

Pearl Therapeutics Inc., a company developing high-quality combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from its first clinical trial in patients with chronic obstructive pulmonary disease (COPD).

5 Jan 2010

Elusys Therapeutics signs contract to complete the final development of Anthim

Elusys Therapeutics, Inc. (Elusys), a privately-held biopharmaceutical company, announced today that it has signed a contract potentially totaling up to $143 million to complete the final development, commercial manufacturing and licensure of Anthim, the company's late stage anthrax therapeutic.

5 Jan 2010

Tactx Medical acquired by Creganna

Creganna, a leading supplier of technologies and services to medical device and lifesciences companies today announced that it has acquired Avalon Medical Services Pte Ltd. which trades as Tactx Medical Inc.

4 Jan 2010

Carbon nanotube: A viable alternative for rapid DNA sequencing

Faster sequencing of DNA holds enormous potential for biology and medicine, particularly for personalized diagnosis and customized treatment based on each individual's genomic makeup.

4 Jan 2010

BiPro completes the requirements of NSF International's Athletic Banned Substances Certification Program

BiProUSA announced today that BiPro, an all natural whey protein isolate (dairy protein), has successfully completed the requirements of NSF International's Athletic Banned Substances Certification Program, Certified for Sport(TM).

4 Jan 2010

HIRU and HTDS announce finalization of MindUp BioResearch Division sale

This is a joint press release of Hiru Corporation (HIRU) and Hard to Treat Diseases (HTDS) - The two companies are pleased to announce the finalization and completion of the purchase and sale of the MindUp BioResearch Division. Details of the transaction completed on cash and stock basis can be found at the Pink Sheets web site www.pinksheets.com under the "filings" tab.

3 Jan 2010

TechPrecision presents strategic plan and outlook for 2010

TechPrecision Corporation (OTC Bulletin Board: TPCS) (“TechPrecision”, or “the Company”), a leading manufacturer of large-scale, high-precision machined metal fabrications with customers in the alternative energy, medical, nuclear, defense, aerospace and other commercial industries, today released the following open letter to shareholders reviewing the highlights of 2009 and providing an overview of the Company’s strategic plan and outlook for 2010.

3 Jan 2010

Anika Therapeutics acquires Fidia Farmaceutici subsidiary FAB

Anika Therapeutics, Inc. today announced that it has acquired Fidia Advanced Biopolymers, s.r.l. (“FAB”), a wholly-owned subsidiary of privately held Italian pharmaceutical company, Fidia Farmaceutici S.p.A. FAB provides hyaluronic acid-based (“HA”) products in several therapeutic areas including for the regeneration of connective and structural tissues damaged by injuries, aging or degenerative diseases.

3 Jan 2010

Pfizer provides update on Prevnar 13

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has not yet completed its review of the Biologics License Application (BLA) for Prevnar 13™, (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company’s candidate 13-valent pneumococcal conjugate vaccine.

31 Dec 2009

Vitro Diagnostics completes private placement of common stock and warrants to raise cash infusion

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the completion of a private placement of its common stock and warrants representing an initial investment of $87,500, with an additional $87,500 should the warrants be exercised, by a group of private investors who previously purchased the Company’s stock at a 36% lower price, through a prior private placement. Please see the associated Form 8-K for additional details regarding this transaction.

31 Dec 2009

Dentists, chiropractors and physical therapists to see rise in revenues from mid-2010: IBISWorld

With the economy showing signs of recovery, industry research firm IBISWorld analyzed more than 700 industries to identify the winning sectors in the coming year.

30 Dec 2009